Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Harris

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Lancet (London, England)|October 3, 2017
Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trialCelina Jin, Malick M Gibani, Maria Moore, et al.
The Lancet. Microbe|April 26, 2026
Nirmatrelvir-ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022-23: virological and immunological results of an open-label randomised trial (PANORAMIC)David M Lowe, Shengyuan Zhang, Samuel Ellis, et al.
International Journal of Radiation Oncology, Biology, Physics|December 12, 2018
Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)David Dearnaley, Clare L Griffin, Rebecca Lewis, et al.
The Lancet. Psychiatry|February 9, 2024
Digitally augmented, parent-led CBT versus treatment as usual for child anxiety problems in child mental health services in England and Northern Ireland: a pragmatic, non-inferiority, clinical effectiveness and cost-effectiveness randomised controlled trialCathy Creswell, Lucy Taylor, Sophie Giles, et al.
Plos Neglected Tropical Diseases|January 6, 2018
Establishing Ebola Virus Disease (EVD) diagnostics using GeneXpert technology at a mobile laboratory in Liberia: Impact on outbreak response, case management and laboratory systems strengtheningPhilomena Raftery, Orla Condell, Christine Wasunna, et al.
Lancet (London, England)|August 13, 2023
Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trialSimon D Kyle, A Niroshan Siriwardena, Colin A Espie, et al.
The Lancet. Psychiatry|May 11, 2019
Equity effects of parenting interventions for child conduct problems: a pan-European individual participant data meta-analysisFrances Gardner, Patty Leijten, Victoria Harris, et al.
Trials|July 4, 2026
TaILOR: a randomised trial to compare the clinical and cost-effectiveness of a patient-initiated follow-up (PIFU) strategy compared to standard care pathways in people with inflammatory arthritis: a study protocolGretchen Brewer, Victoria Harris, Christoper Mwema, et al.
Infection|October 9, 2024
Correction: Performance evaluation of a combination Plasmodium dual-antigen CRP rapid diagnostic test in Lambaréné, GabonAyodele Alabi, Fungai P Musangomunei, Fabrice Lotola-Mougeni, et al.
Infection|August 23, 2024
Performance evaluation of a combination Plasmodium dual-antigen CRP rapid diagnostic test in Lambaréné, GabonAyodele Alabi, Fungai P Musangomunei, Fabrice Lotola-Mougeni, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Lancet (London, England)|October 3, 2017
Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trialCelina Jin, Malick M Gibani, Maria Moore, et al.
The Lancet. Microbe|April 26, 2026
Nirmatrelvir-ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022-23: virological and immunological results of an open-label randomised trial (PANORAMIC)David M Lowe, Shengyuan Zhang, Samuel Ellis, et al.
International Journal of Radiation Oncology, Biology, Physics|December 12, 2018
Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)David Dearnaley, Clare L Griffin, Rebecca Lewis, et al.
The Lancet. Psychiatry|February 9, 2024
Digitally augmented, parent-led CBT versus treatment as usual for child anxiety problems in child mental health services in England and Northern Ireland: a pragmatic, non-inferiority, clinical effectiveness and cost-effectiveness randomised controlled trialCathy Creswell, Lucy Taylor, Sophie Giles, et al.
Plos Neglected Tropical Diseases|January 6, 2018
Establishing Ebola Virus Disease (EVD) diagnostics using GeneXpert technology at a mobile laboratory in Liberia: Impact on outbreak response, case management and laboratory systems strengtheningPhilomena Raftery, Orla Condell, Christine Wasunna, et al.
Lancet (London, England)|August 13, 2023
Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trialSimon D Kyle, A Niroshan Siriwardena, Colin A Espie, et al.
The Lancet. Psychiatry|May 11, 2019
Equity effects of parenting interventions for child conduct problems: a pan-European individual participant data meta-analysisFrances Gardner, Patty Leijten, Victoria Harris, et al.
Trials|July 4, 2026
TaILOR: a randomised trial to compare the clinical and cost-effectiveness of a patient-initiated follow-up (PIFU) strategy compared to standard care pathways in people with inflammatory arthritis: a study protocolGretchen Brewer, Victoria Harris, Christoper Mwema, et al.
Infection|October 9, 2024
Correction: Performance evaluation of a combination Plasmodium dual-antigen CRP rapid diagnostic test in Lambaréné, GabonAyodele Alabi, Fungai P Musangomunei, Fabrice Lotola-Mougeni, et al.
Infection|August 23, 2024
Performance evaluation of a combination Plasmodium dual-antigen CRP rapid diagnostic test in Lambaréné, GabonAyodele Alabi, Fungai P Musangomunei, Fabrice Lotola-Mougeni, et al.
Pageof 9